Literature DB >> 19454472

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

J Bellmunt1, S Albiol, V Kataja.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454472     DOI： 10.1093/annonc/mdp136

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  [Not Available].

Authors:  Christopher M Booth; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

2.  Delivering high-quality care to patients with muscle-invasive bladder cancer: Insights from routine practice in Ontario.

Authors:  Christopher M Booth; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

3.  Optimizing care and outcomes of patients with muscle-invasive bladder cancer.

Authors:  Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

4.  Perioperative chemotherapy for muscle-invasive bladder cancer: Closing the gap between evidence and practice.

Authors:  Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

5.  Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Authors:  Marco Bandini; Alberto Briganti; Elizabeth R Plimack; Günter Niegisch; Evan Y Yu; Aristotelis Bamias; Neeraj Agarwal; Srikala S Sridhar; Cora N Sternberg; Ulka Vaishampayan; Christine Théodore; Jonathan E Rosenberg; Joaquim Bellmunt; Matthew D Galsky; Francesco Montorsi; Andrea Necchi
Journal:  Eur Urol Oncol       Date:  2018-09-07

Review 6.  Vinflunine.

Authors:  James E Frampton; Marit D Moen
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

7.  Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour.

Authors:  Melanie Walker; R Christopher Doiron; Simon D French; Deb Feldman-Stewart; D Robert Siemens; William J Mackillop; Christopher M Booth
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

8.  Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.

Authors:  Melanie Walker; R Christopher Doiron; Simon D French; Kelly Brennan; Deb Feldman-Stewart; D Robert Siemens; William J Mackillop; Christopher M Booth
Journal:  Bladder Cancer       Date:  2018-01-20

9.  Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis.

Authors:  Lezhong Chen; Xinghuan Wang
Journal:  Oncol Lett       Date:  2018-10-05       Impact factor: 2.967
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.